ideology-health
  • Our Solutions
  • About Us
    • ideology-health
    Privacy Policy
    Terms of Service
    Inc. 5000

    IDEOlogy Health Ranks No. 772 on the 2025 Inc. 5000 Fastest-Growing Private Companies in America

    © 2026 IDEOlogy Health. All product names, logos, brands, trademarks and registered trademarks are property of their respective owners and their use(s) do not necessarily imply endorsement.

    L

    Dr Laura van 't Veer, PhD

    Medical professional dedicated to sharing knowledge and insights through educational videos.

    Dr. Laura van ‘t Veer describes the residual cancer burden with ctDNA in breast cancer (Video 3/3)

    Dr. Laura van ‘t Veer describes the residual cancer burden with ctDNA in breast cancer (Video 3/3)

    ctDNA and RCB

    Laura van 't Veer, PhD
    Breast Cancer
    Dr. Laura van ‘t Veer reviews ctDNA clearance at week 3 as an early indicator in breast cancer (Video 2/3)

    Dr. Laura van ‘t Veer reviews ctDNA clearance at week 3 as an early indicator in breast cancer (Video 2/3)

    ctDNA Week 3 Indicator

    Laura van 't Veer, PhD
    Breast Cancer
    Dr. Laura van ‘t Veer discusses baseline ctDNA as a predictive marker in neoadjuvant breast cancer (Video 1/3)

    Dr. Laura van ‘t Veer discusses baseline ctDNA as a predictive marker in neoadjuvant breast cancer (Video 1/3)

    ctDNA Baseline

    Laura van 't Veer, PhD
    Breast Cancer